Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLEC12A antisense RNA 1 (CLEC12A-AS1) is a long non-coding RNA (lncRNA) gene located at chromosome 12p13.31. Its RNA transcript is transcribed antisense to the CLEC12A protein-coding gene, and as with other antisense lncRNAs, it may have regulatory roles, possibly modulating the expression of nearby genes such as CLEC12A. However, there is currently no published functional or disease association, no known interacting drugs, and no evidence that it is a direct therapeutic target or biomarker. Its identification in genomic databases confirms its existence as a lncRNA but not its function or importance in human disease or therapy[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CLEC12A antisense RNA 1 (CLEC12A-AS1).